Vladimir Chulanov, MD, PhD

Sechenov University, Russia

Disclosure(s): AbbVie: Consultant/sponsored lectures; AstraZeneca: Consultant/sponsored lectures; Bristol Myers Squibb: Consultant/sponsored lectures; Gilead Sciences, Inc.: Consultant/sponsored lectures; GSK: Consultant/sponsored lectures; Hepatera: Consultant/sponsored lectures; Merck Sharp & Dohme: Consultant/sponsored lectures; Roche: Consultant/sponsored lectures; R-Pharm: Consultant/sponsored lectures

Poster(s):

• (P-2195) Influence of Nucleos(t)ide Analogue Use with Bulevirtide on Treatment Outcomes in Chronic Hepatitis Delta
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET